What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Gene
His scientific interests lie mostly in Internal medicine, Endocrinology, Gastroenterology, Fatty liver and Nonalcoholic fatty liver disease.
His study in Hepatology, Liver biopsy, Steatosis, Insulin resistance and Metabolic syndrome falls under the purview of Internal medicine.
His Endocrinology research includes elements of Inflammation, Peroxisome proliferator-activated receptor, Receptor and Colorectal cancer.
His Gastroenterology study combines topics in areas such as Area under the curve, Aspirin, Steatohepatitis and Prospective cohort study.
His work investigates the relationship between Fatty liver and topics such as Fibrosis that intersect with problems in Pathogenesis.
His work focuses on many connections between Nonalcoholic fatty liver disease and other disciplines, such as Case-control study, that overlap with his field of interest in Alpha-Ketoglutarate-Dependent Dioxygenase FTO and Odds ratio.
His most cited work include:
- Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography (357 citations)
- FOXP3+ regulatory T cells affect the development and progression of hepatocarcinogenesis (347 citations)
- Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD) (344 citations)
What are the main themes of his work throughout his whole career to date?
Atsushi Nakajima spends much of his time researching Internal medicine, Gastroenterology, Endocrinology, Surgery and Pathology.
His research related to Fatty liver, Hepatology, Nonalcoholic fatty liver disease, Colorectal cancer and Cancer might be considered part of Internal medicine.
Atsushi Nakajima has included themes like Liver biopsy and Transient elastography in his Fatty liver study.
As a part of the same scientific family, Atsushi Nakajima mostly works in the field of Cancer, focusing on Cancer research and, on occasion, Carcinogenesis.
His Gastroenterology research is multidisciplinary, incorporating perspectives in Colonoscopy and Fibrosis.
Atsushi Nakajima frequently studies issues relating to Receptor and Endocrinology.
He most often published in these fields:
- Internal medicine (59.58%)
- Gastroenterology (38.79%)
- Endocrinology (13.70%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (59.58%)
- Gastroenterology (38.79%)
- Fatty liver (10.57%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Internal medicine, Gastroenterology, Fatty liver, Nonalcoholic fatty liver disease and Fibrosis.
His study looks at the intersection of Internal medicine and topics like Placebo with Adverse effect.
His work on Transient elastography, Cirrhosis and Steatosis as part of his general Gastroenterology study is frequently connected to In patient, thereby bridging the divide between different branches of science.
His Fatty liver research integrates issues from Liver disease and Receiver operating characteristic.
The Nonalcoholic fatty liver disease study which covers Hepatocellular carcinoma that intersects with Liver transplantation.
His studies in Hepatology integrate themes in fields like Cold snare, Colorectal cancer, Polypectomy and Abdominal surgery.
Between 2017 and 2021, his most popular works were:
- Modeling NAFLD Disease Burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030 (328 citations)
- Magnetic Resonance vs Transient Elastography Analysis of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Pooled Analysis of Individual Participants. (88 citations)
- Patients with colorectal cancer have identical strains of Fusobacterium nucleatum in their colorectal cancer and oral cavity. (57 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Gene
Atsushi Nakajima mostly deals with Internal medicine, Gastroenterology, Fatty liver, Nonalcoholic fatty liver disease and Hepatology.
His Internal medicine study frequently draws parallels with other fields, such as Placebo.
His Gastroenterology research is multidisciplinary, incorporating elements of Biopsy and Liver biopsy.
Atsushi Nakajima interconnects Liver disease and Receiver operating characteristic in the investigation of issues within Fatty liver.
His Nonalcoholic fatty liver disease research incorporates themes from Methylation, Advanced fibrosis, Inflammation, Diabetes mellitus and Hepatocellular carcinoma.
His Hepatology study combines topics from a wide range of disciplines, such as Incidence, Complication, Surgical oncology and Colorectal surgery, Abdominal surgery.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
